FDA Announces Joint Meeting of Advisory Committees, Requests Public Comments

Summary

The Food and Drug Administration (FDA) is hosting a joint meeting of its Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee, during which the public will have the opportunity to provide input on the committees' recommendations, with at least one portion of the meeting closed to the public.